For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Citation
Agencies Target ‘Blackout in a Can’
Citation
Greg Conko on “Frankenfish”
Competitive Enterprise Institute Senior Fellow Gregory Conko discusses the benefits and safety of genetically engineered foods. Humans have altered the genetic material of their food…
Fox News
FDA’s Graphic Warnings for Cigarettes: Noble Ad Campaign or Nanny State at Work?
Legal Brief
Amicus Motion in Obamacare Litigation
The Competitive Enterprise Institute is representing Governors Tim Pawlenty (R, Minn.) and Donald Carcieri (R, Rhode Island) seeking permission to file an amicus brief in…
Philly.com
Pawlenty Joins in Overhaul Suit
Google News